Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation

FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation
ShareXFacebook

(MedPage Today) -- The FDA expanded the indication for dextromethorphan hydrobromide and bupropion hydrochloride (Auvelity) extended-release tablets to treat agitation associated with Alzheimer's disease dementia, the agency announced Thursday...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement